Well the good news is they kept Q2 spend to $736K, almost $140K...

Well the good news is they kept Q2 spend to $736K, almost $140K below their estimate of $874K in the last quarterly.

With $543K remaining, if they keep to their Q3 estimate of $416K it will leave them with only $127K at the end of Q3 so money will be needed from somewhere before the end of the year.

In December this year, MLSO options expire. With a conversion price of 0.3c that would bring in just over $645K if all were converted. If the assay results can get some wind in the sails this could become a real possibility.. surely this is motivation for management to get out there and build some confidence in the company off successful results!

If they can keep the momentum up from there, MLSOA expire in May next year.. conversion price of 1c. Fully converted that would bring in $9.2m. The kind of money that could really change the game. Of course to achieve that, they would really need the SP comfortably over 1c. Might be a big call, but $9m dollars would get me focused on achieving it!